Early aggressive treatment with DMARDs vs. step-up therapy in rheumatoid arthritis: a traditional review of joint damage and functional outcomes
Journal of Basic and Clinical Physiology and Pharmacology · 2026
DOI: 10.1515/jbcpp-2025-0060 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Basic and Clinical Physiology and Pharmacology, 2026. Verfasst von Amruth Akhil Alluri und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, American University of the Caribbean School of Medicine, Cupecoy, Sint Maarten. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Antirheumatic Agents, Joints. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 114 Literaturangaben.
Abstract (Originalsprache)
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by progressive joint inflammation and structural damage. Two primary treatment strategies – step-up therapy and early aggressive DMARD therapy have been widely debated in clinical practice. The step-up approach begins with NSAIDs or corticosteroids, progressing to DMARDs based on disease severity, whereas early aggressive therapy prioritizes immediate DMARD initiation to prevent irreversible joint damage. This comprehensive review evaluates the effectiveness of these strategies by analyzing randomized controlled trials (RCTs), meta-analyses, and cohort studies assessing treatment outcomes, remission rates, and radiographic progression. A literature search was conducted across PubMed, Scopus, and Web of Science, including studies published between 2010 and 2024. Key clinical trials, including TICORA, COBRA, BeSt, and CAMERA, were critically analyzed to assess the comparative benefits and limitations of both treatment approaches. Evidence suggests that early aggressive therapy is associated with higher remission rates, reduced radiographic progression, and improved long-term physical function, whereas the step-up approach often leads to delayed disease control and cumulative joint damage. However, concerns related to treatment adherence, cost-effectiveness, and safety profiles necessitate further investigation. Future research should focus on biomarker-driven personalized treatment strategies, optimizing drug sequencing, and long-term comparative effectiveness studies to refine RA management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, American University of the Caribbean School of Medicine, Cupecoy, Sint Maarten.
- Department of Internal Medicine, Shrimati Kashibai Navale Medical College and General Hospital, Pune, Maharashtra, India.
- Department of Internal Medicine, American University of Barbados, Wildey, Bridgetown, Saint Michael, Barbados.
- Department of Internal Medicine, Atal Bihari Vajpayee Institute of Medical Sciences and Dr. Ram Manohar Lohia Hospital, New Delhi, India.
- Research scholar, Manipal college of Nursing, Manipal Academy of Higher Education, Manipal, Karnataka, India.
ORCID-Profile: Amruth Akhil Alluri, Rohan Singhal, Swathi N L
Zitieren
APA
Akhil Alluri, A., Rajesh Pawar, A., Prakash Khetan, S., Singhal, R., Suresh Suvarna, S., Ravindra Adsure, M., & N L, S. (2026). Early aggressive treatment with DMARDs vs. step-up therapy in rheumatoid arthritis: a traditional review of joint damage and functional outcomes. Journal of Basic and Clinical Physiology and Pharmacology. https://doi.org/10.1515/jbcpp-2025-0060
Vancouver
Akhil Alluri A, Rajesh Pawar A, Prakash Khetan S, Singhal R, Suresh Suvarna S, Ravindra Adsure M, et al. Early aggressive treatment with DMARDs vs. step-up therapy in rheumatoid arthritis: a traditional review of joint damage and functional outcomes. Journal of Basic and Clinical Physiology and Pharmacology. 2026. doi:10.1515/jbcpp-2025-0060
BibTeX
@article{AkhilAlluri2026,
author = {Akhil Alluri, Amruth and Rajesh Pawar, Aditya and Prakash Khetan, Shrishti and Singhal, Rohan and Suresh Suvarna, Shruti and Ravindra Adsure, Mehal and N L, Swathi},
title = {Early aggressive treatment with DMARDs vs. step-up therapy in rheumatoid arthritis: a traditional review of joint damage and functional outcomes},
journal = {Journal of Basic and Clinical Physiology and Pharmacology},
year = {2026},
doi = {10.1515/jbcpp-2025-0060}
}
EUVIMED